| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RGA | Common Stock | Options Exercise | $80K | +888 | +13.38% | $90.06 | 7.52K | Feb 7, 2024 | Direct | F1 |
| transaction | RGA | Common Stock | Tax liability | -$87.4K | -517 | -6.87% | $169.01 | 7.01K | Feb 7, 2024 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RGA | Stock Appreciation Right (right to purchase) 2015 | Options Exercise | $0 | -1.9K | -100% | $0.00* | 0 | Feb 7, 2024 | Common Stock | 1.9K | $90.06 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Represents (i) 1,014 shares sold to pay the exercise price the purchase of Common Stock, and (ii) 517 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 371 shares. |
| F2 | SARs grants vest in 25% increments over four years, starting on December 31 of the year of grant. |